Comparative risk evaluation of cardiovascular events in patients without atherosclerotic cardiovascular disease receiving Empagliflozin versus Empagliflozin
Latest Information Update: 08 Dec 2020
At a glance
- Drugs Dapagliflozin (Primary) ; Empagliflozin (Primary)
- Indications Cardiovascular disorders; Heart failure; Myocardial infarction; Stroke; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Nov 2019 New trial record